학술논문
CML-395 Efficacy and Safety Results From ASCEMBL, a Phase III Study of Asciminib vs. Bosutinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After ≥2 Prior Tyrosine Kinase Inhibitors (TKIs): Week 96 Update
Document Type
Article
Author
Réa, Delphine ; Hochhaus, Andreas ; Mauro, Michael J. ; Minami, Yosuke ; Lomaia, Elza ; Voloshin, Sergey ; Turkina, Anna ; Kim, Dong-Wook ; Apperley, Jane F. ; Cortes, Jorge E. ; Abdo, Andre ; Fogliatto, Laura Marie ; Kim, Dennis Dong Hwan ; Coutre, Philipp le ; Saussele, Susanne ; Annunziata, Mario ; Hughes, Timothy P. ; Chaudhri, Naeem ; Chee, Lynette ; García-Gutiérrez, Valentin ; Sasaki, Koji ; Kapoor, Shruti ; Allepuz, Alex ; Quenet, Sara ; Bédoucha, Véronique ; Boquimpani, Carla
Source
In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S295-S296
Subject
Language
ISSN
2152-2650